ESOI TOUCHDOWN 2025 MALTA
Dear Colleagues & Friends,
It is both a privilege and a pleasure to welcome you to the ESOI Touchdown 2025, which will take place from November 13th to 15th in Qawra, Malta.
At the crossroads of Europe, North Africa, and the Middle East, Malta has a longstanding tradition of academic excellence and cultural exchange. Today, it continues this legacy as a growing hub for research, education, and clinical excellence through Mater Dei Hospital and the University of Malta, which collaborate closely in multiple European and international initiatives.
The 2025 Annual Meeting promises to deliver a comprehensive scientific programme, showcasing the latest advances in oncologic imaging. It aims to foster dialogue among radiologists, clinicians, researchers, and industry stakeholders, strengthening multidisciplinary collaboration. Consistent with ESOI’s mission, the meeting will serve as a platform for education, innovation, and professional growth in a collegial and stimulating setting. Of note, this year’s programme features a dedicated focus on enhancing radiologist – patient communication, highlighting its important role in contemporary oncologic care.
Malta offers a unique setting for this year’s congress. The island provides an inspiring backdrop for scientific exchange and will enrich both your professional and personal experience.
On behalf of the ESOI Executive Committee, I extend my sincere invitation to join us in Malta for what promises to be a very engaging and memorable ESOI Touchdown Meeting,
Dr. Melvin D’Anastasi
ESOI President and Congress President
GENERAL INFORMATION
The ESOI Touchdown 2025 will take place as an in-person event only. Online or on-demand participation will not be available.
Limitation of Liability
There is neither any liability nor any obligation of ESOI in case of cancellation of an ESOI congress for whatever reasons. Apart from damages caused by physical injury, the liability of ESOI for damages of any other kind shall be restricted to wilful intent or gross negligence. ESOI shall not be liable for any damages caused by force majeure.
Congress Language
The congress will be held in English.
Congress President
Dr. Melvin D’Anastasi, Msida/MT
Date
November 13-15, 2025
ESOI Touchdown 2025 Malta
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Organising Secretariat
ESOI – European Society of Oncologic Imaging
Am Gestade 1
1010 Vienna, Austria
Phone: +43 1 5334064-924
Email: office@esoi-society.org
ACCOMMODATION & TRAVEL
Special rates for accommodation at AX ODYCY Hotel Qawra
We are happy to announce that a number of rooms at the congress hotel have been secured for delegates of the ESOI Touchdown 2025 Malta.
Please note that room bookings are managed by AX ODYCY Hotel Qawra. For any questions or inquiries, kindly contact the hotel directly.
ESOI cannot accept any liability for external services.
The special booking rates are valid for bookings made until July 31, 2025. After this date, nightly rates may vary.
When booking directly on the AX ODYCY website, please manually apply the promo code AXGRPESOI-A2025.
Special flight discount with KM Malta Airlines
If you book your flight tickets to ESOI Touchdown 2025 Malta directly through the KM Malta Airlines website by June 25, 2025, you will receive a 15% discount on travel between November 10 and 18, 2025, using the promo code EUSOIKMMA25.
How to apply the promo code:
- Visit KM Malta Airlines website
- Enter the promo code EUSOIKMMA25 in the “Add Promo Code” field
- Fill in your travel details (departure/arrival, dates, and number of passengers)
- Click “Search” to view available flights
- Choose your preferred flights and fare brand, then click “Continue”
- Repeat the process for your return flight
- Proceed to enter passenger details and complete your payment to confirm your e-ticket.
Please note: The promo code EUSOIKMMA25 is only valid for flight bookings made by June 25, 2025 and applies exclusively to travel dates between November 10 and 18, 2025. It is valid on all KM Malta Airlines-operated flights (excluding codeshare flights) and can be used for all cabin classes, including Economy and Business.
REGISTRATION IS OPEN
ESOI Touchdown 2025 Malta – Registration Fees
| Early Registration until August 3 |
Late Registration until November 9 |
Onsite Registration until November 15 |
|
| Regular Fee | 550,00 € | 660,00 € | 695,00 € |
| ESOI Full/Allied Sciences Member Fee | 395,00 € | 550,00 € | 585,00 € |
| Regular Resident Fee | 265,00 € | 365,00 € | 395,00 € |
| ESOI Resident Member Fee | 210,00 € | 310,00 € | 335,00 € |
ESOI is a registered Austrian non-profit organization and therefore does not charge VAT.
Registration Deadlines
Early Registration Fee until Sunday, August 3, 2025 (23:45 CEST)
Late Registration Fee until Sunday, November 9, 2025 (23:45 CET)
Onsite Registration Fee until Saturday, November 15, 2025
Member Registration
Reduced member registration is available for all active ESOI members in 2025.
Resident Registration
Reduced resident registration will be offered to residents (young radiologists in training). Residents have to send or email a letter, written on official hospital letter paper and signed by the head of department, confirming their status as such within 5 working days after online registration. In case this confirmation is not received, the registration fee will automatically be adjusted to a regular fee. The age limit for a registration as resident/junior is set at 35 years (incl. the age of 35).
Delegate Registration Fee Includes
– Admittance to all lectures and workshops
– Admittance to the technical exhibition
– Certificate of attendance
– Coffee breaks
Terms & Conditions | Cancellation Policy
Please CLICK HERE to download the Terms & Conditions as well as the Cancellation Policy.
ACCREDITATION INFORMATION
Confirmation of Attendance
Each participant who attends the live event (November 13-15) will receive the confirmation of attendance document via email after the congress.
IMPORTANT: Due to UEMS regulations, attendees can only claim CME credits for the sessions that have actually been attended during the event. You will need to evaluate each session that you attended and would like to receive credits for on the event evaluation form. As part of this process participants’ attendance will be monitored throughout the event.
UEMS CME Accreditation
Persons who attend the live event (November 13-15) and who successfully evaluate the congress will receive the CME certificate via email mid-December 2025. UEMS CME evaluation deadline: Sunday, November 23, 2025
The ESOI Touchdown 2025 Malta, Qawra, Malta 13/11/2025 – 15/11/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 16.5 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Please find below the breakdown of ECMEC®s per day:
13.11.2025 – 6.0
14.11.2025 – 6.5
15.11.2025 – 4.0
ABSTRACT SUBMISSION IS CLOSED
Notifications of acceptance/rejection have been sent. In case of any questions, please do not hesitate to contact the ESOI Office.
General Information
We are pleased to invite all interested individuals to submit an abstract for this year’s ESOI Touchdown 2025 Malta. For presenting authors of accepted abstracts, registration and on-site participation at ESOI Touchdown 2025 Malta is mandatory. The best authors will receive free registration for the next ESOI Touchdown in 2026.
Abstract Structure
Submissions can be made in one of the following three categories: oral presentation, scientific poster, or educational poster. Abstracts are limited to a maximum of 2,750 characters, including spaces. More information regarding abstract guidelines can be found here.
Accepted Oral Presentations
Authors of the highest-rated oral abstracts will be invited to present their work during ESOI Touchdown 2025 Malta. Presentations should be prepared in PowerPoint format. Please adhere to the allotted speaking time as outlined in the programme overview. All presenters will have the opportunity to upload their presentation on-site. Kindly ensure your file is uploaded at least two hours prior to the start of your session.
Accepted Poster Presentations
Authors of top-scoring poster abstracts will be invited to display their work at ESOI Touchdown 2025 Malta. Accepted posters must be prepared in A1 portrait format. Poster presenters are required to bring their printed posters to Malta and display them on the designated poster walls.
Important Deadlines
Submission Deadline: Monday, June 30, 2025 (23:59 CEST)
Notifications of acceptance/rejection will be sent in July.
PROGRAMME
Thursday, November 13
Room 1
08:30-08:45 Opening Session
M. D’Anastasi, Msida/MT & J-E. Abela (Minister for Health and Active Ageing), Valletta/MT (VIDEO)
08:45-10:00 ESOI Meets ESR PAG
M. D’Anastasi, Msida/MT & E. Neri, Pisa/IT
08:45 Enhancing Radiologist-Patient Communication, D. Carrie, Toulouse/FR
09:05 Transforming Healthcare towards Patient-Centred Care, C. Justich, Vienna/AT
09:25 Panel Discussion: The Radiologist’s Role in Patient-Centred Oncology Care, All speakers
10:00-10:30 Coffee Break
10:30-12:00 Multidisciplinary Team Session – Pancreatic MDT Simulation
10:30 Part 1: Cystic Pancreatic Neoplasms
11:15 Part 2: Solid Pancreatic Neoplasms – Operable and Inoperable Tumours
Radiologists: C. Cannataci, Msida/MT & K. Cortis, Msida/MT
Oncologist: M. Mifsud, Msida/MT
Surgeon: N. Cassar, Msida/MT
12:00-12:10 Break
12:10-13:00 Industry sponsored Symposium “Spectral CT in Oncologic Imaging”
D. Caruso, Rome/IT & C. De Molina Gomez, Madrid/ES
13:00-13:30 Break
13:30-13:50 Keynote Lecture
M. D’Anastasi, Msida/MT
Oncologic Imaging at the Nexus of Global Health – The Time is Now!, H. Hricak, New York/US
13:50-13:55 Break
13:55-15:15 Haematological Malignancies
F. Gallagher, Cambridge/UK & H. Vardevanyan, Yerevan/AM
13:55 Lymphoma: Current practice guidelines for staging and response assessment, D. Leithner, New York/US
14:15 Myeloma: Which imaging test and when?, M. Mayerhöfer, New York/US
14:35 CNS Manifestations of Haematological Malignancies, R. Grech, Msida/MT
14:55 Interactive Cases, All speakers
15:15-15:20 Break
15:20-16:20 Workshop 1: Patient Communication Simulation: Breaking Bad News
D. Carrie, Toulouse/FR & B. Chase, Msida/MT & C. Justich, Vienna/AT
16:20-16:50 Coffee Break
16:50-17:50 Scientific Session 1: Assessment of treatment response/follow-up
D. Lambregts, Amsterdam/NL & M.F. Reiser, Munich/DE
16:55 Contrast-enhanced ultrasound with VEGFR2-targeted microbubbles for monitoring combined anti-PD-L1/anti-CTLA-4 immunotherapy effects in a murine melanoma model with immunohistochemical validation, F. Herr, Munich/DE
17:01 CT-based Body Composition Assessment as a Predictor of Clinical Outcomes in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors, D. Capece, Rome/IT
17:07 Vacuum-Assisted Excision for DCIS: Preliminary Results of a Prospective Study, L. Nicosia, Milan/IT
17:13 Body composition as a predictor of cancer-specific death in colon cancer: An AI-based volumetric analysis, M. Polici, Rome/IT
17:19 Predicting laboratory changes during immunotherapy of metastatic melanoma using whole-organ radiomics signatures, L.T. Rotkopf, Heidelberg/DE
17:25 Deep-learning models outperform conventional radiomics for lesion-level response prediction in metastatic melanoma therapy monitoring, L.T. Rotkopf, Heidelberg/DE
17:31 Use of the MetroPancreas algorithm and tumor imaging features to reduce futile resections in patients with PDAC, I. Panozzo, Verona/IT
17:37 Early volumetric change outperforms radiomics for lesion-level immunotherapy response in metastatic melanoma, L.T. Rotkopf, Heidelberg/DE
17:50-18:20 Poster Walking Tour (Poster Exhibition, Level -1)
Room 2
15:20-16:20 Workshop 2: Therapy Complications in Oncological Patients (CNS, Thorax, Abdomen)
W. Kunz, Munich/DE & D. Lambregts, Amsterdam/NL & S. Shivalingappa, Bangalore/IN
16:20-16:50 Coffee Break
16:50-17:50 Scientific Session 2: Radiomics/AI
L. Beer, Vienna/AT & D. Cioni, Pisa/IT
16:55 Correlation Between Manual and Automated Whole-Body Tumor Volume Assessment in [¹⁸F] FDG-PET/CT: A Comparative Analysis of Segmentation Methods, R. Ebner, Munich/DE
17:01 Privacy-Preserving Large Language Models to Extract Response Assessments from Radiology Reports in Immunotherapy Trials, L.T. Rotkopf, Heidelberg/DE
17:07 Beyond Biopsy: Predicting PD-L1 Status in Non-small cell Lung Cancer Through CT Radiomics, V. Solimene, Rome/IT
17:13 Quality assessment of the Prostate-NET: A large European multicentre dataset, D. Froli, Turin/IT
17:19 Clinical validation of an AI system for Prostate Cancer detection: Comparison between assisted and unassisted reading, M. Catania, Turin/IT
17:25 LLMs Software Performance Evaluation for Prostate mpMRI Reports Interpretation, B. Masci, Rome/IT
17:31 Applying Artificial Intelligence to the Detection of Secondary Bone Lesions on CT, M. Durteste, Paris/FR
17:37 Longitudinal AI-Based Body Composition Analysis of Routine Clinical CT Scans for Predicting Overall Survival in Pancreatic Ductal Adenocarcinoma, F. Herr, Munich/DE
Room 3
15:20-16:20 Workshop 3: Errors in Oncologic Imaging
A. Borgheresi, Ancona/IT & G. Cappello, Turin/IT
16:20-16:50 Coffee Break
16:50-17:50 Scientific Session 3: Diagnosis/staging
S. Gourtsoyianni, Athens/GR & S. Grosu, Munich/DE
16:55 Optimizing Contrast Dose in Liver CT with Spectral Dual-Layer CT: Implications for Oncologic Imaging, B. Masci, Rome/IT
17:01 The role of CT scan in predicting complete cytoreduction during primary debulking surgery for advanced epithelial ovarian cancer, P. Ghosh, Kolkata/IN
17:07 Improving Consistency in the Membranous Urethral Length Measurement on Prostate MRI through Various Methods of Online Training, E.P. Goedegebuure, Amsterdam/NL
17:13 Peritumoral immune signatures and immune cytotoxicity: Biomarkers to support neuroradiologic grading, C. Giordano, Naples/IT
17:19 Subjective Image Quality and Lesion Visibility in Hepatic and Pancreatic Imaging Using PCCT-Derived Virtual Monoenergetic Images and Iodine maps, F. Haag, Mannheim/DE
17:25 Prognostic Value of Diffuse Marrow Activity in Smouldering Multiple Myeloma: A Real-World Imaging-Based Study with WBMRI and PET/CT, F. Pucchiarelli, Rome/IT
17:31 Diagnostic accuracy of CT for identifying high-risk colon cancer: A systematic review and meta-analysis, J. Shkurti, Amsterdam/NL
17:37 Radiological accuracy in staging T3/T4 Laryngeal carcinoma, G. Raj, Lucknow/IN
17:43 Optimal scan time for [18F]SiTATE PET/CT imaging of patients with neuroendocrine Tumors, R. Ebner, Munich/DE
Room 4
15:20-16:20 Workshop 4: Lung Cancer Staging: Challenging cases and tips from the experts
G. Cicchetti, Rome/IT & A.R. Larici, Rome/IT
16:20-16:50 Coffee Break
16:50-17:50 Scientific Session 4: Other oncological imaging topics
D. Caruso, Rome/IT & G. Zamboni, Verona/IT
16:55 Response and progression patterns of GEP-NET following 177Lu DOTA-TATE PRRT in multimodality imaging, C. Dascalescu, Munich/DE
17:01 Structured Reporting and Contrast-Enhanced Ultrasound in Testicular Tumor Assessment: Enhancing Diagnostic Clarity and Clinical Decision-Making, M.L. Schnitzer, Munich/DE
17:07 Wire-Assisted Trans-urEthral Replacement of ureteral Stent (WATERS): A cost-effective alternative to snare-loop technique in patients with gynecological malignancies, A. Posa, Rome/IT
17:13 Unilocular non-communicating cystic lesions of the pancreas: Unraveling a complex differential diagnosis, F. Omboni, Verona/IT
17:19 Diagnostic accuracy of preoperative ultrasound including fine needle cytology of sentinel nodes in melanoma patients, A.E. Berstad, Oslo/NO
17:25 Optimizing Spectral Reconstruction Sets in Dual-Layer CT for Oncologic Imaging: Diagnostic Impact and Workflow Efficiency, L. Nardoni, Rome/IT
17:31 Integrated biomarkers for predicting OS in GEP-NET under four cycles PRRT, C. Dascalescu, Munich/DE
17:37 Evaluation of Virtual Non-Contrast Reconstructions from Dual-Layer Spectral CT in Oncologic Abdominal Imaging, A. Del Gaudio, Rome/IT
Friday, November 14
Room 1
08:00-08:25 Industry sponsored Symposium – Breakfast Briefing “Advancements in Photon Counting CT – Image Quality, Spectral Imaging”
Moderator: V. Kneissl, Forchheim/DE / Speaker: H-C. Becker, Stanford/US
08:25-08:30 Break
08:30-09:30 Workshop 5: Breast MDT
E. Borg, Msida/MT & M. Ceci, Msida/MT & C. Magri, Msida/MT & J. Muscat, Msida/MT & L. Sammut, Msida/MT
09:30-09:40 Break
09:40-10:40 Peritoneal Carcinomatosis
K. Chircop, Msida/MT & I. Saliba, Msida/MT
09:40 Ovarian cancer cytoreduction – An ultraradical approach, M. Brincat, Msida/MT
10:00 How can we help the surgeon?, S. Nougaret, Montpellier/FR
10:20 Clinical Cases, V. Cassar, Msida/MT & M. D’Anastasi, Msida/MT & S. Nougaret, Montpellier/FR
10:40-11:10 Coffee Break
11:10-12:25 Novel Developments in Oncological Imaging and Integrative Diagnostics
L. Fournier, Paris/FR & M. Frölich, Mannheim/DE
11:10 Data-driven Approaches for Oncological Imaging, D. Pinto dos Santos, Cologne/DE
11:25 Advancing Clinical Research Through Oncologic Imaging Innovations, L. Russo, Rome/IT
11:40 Precision in Action: Image-guided Cancer Therapies and Personalised Treatment Strategies, M. Seidensticker, Munich/DE
11:55 The Oncologic Imaging Expert of Tomorrow: Navigating AI, Quantitative Data and Integrative Diagnostics, S. Schönberg, Mannheim/DE
12:10 Panel Discussion: How can today’s radiologist prepare for the future?, All speakers
12:25-12:35 Break
12:35-13:25 Industry sponsored Symposium “Multiparametric Ultrasound of the Liver: Advances in Early Detection and HCC Characterization”
Ajdin Smajlovic
13:25-14:00 Break
14:00-15:30 Multidisciplinary Team Session – Head and Neck MDT Simulation
14:00 Part 1: Oncological Cases of the Oral Cavity, Pharynx and Larynx
14:45 Part 2: Oncological Cases of the Major Salivary Glands
Radiologists: E. Vassallo, Msida/MT & A. Venkatasamy, Paris/FR
Oncologists: N. Refalo, Msida/MT & K. Taliana, Msida/MT
ENT Surgeon: K. Muscat, Msida/MT
15:30-16:00 Coffee Break
16:00-17:00 Driving Innovation in AI Development: Data Sharing Across Europe with the EUCAIM Platform
P. Rudenko, Valencia/ES & H-P. Schlemmer, Heidelberg/DE
16:00 Introduction of EUCAIM, H-P. Schlemmer, Heidelberg/DE
16:10 EUCAIM Stakeholder Engagement, S. Flor Arnal, Valencia/ES
16:25 EUCAIM Data Federation and Interoperability Framework, V. Kalokyri, Iraklion/GR
16:45 Overview of Core Services and Sustainability and Integration in the EHDS, H. Leisz, Heidelberg/DE
17:00-18:00 Workshop 8: Cervical cancer staging with MRI: Basic and challenging cases
N. Bonanno, Birkirkara/MT & L. Fournier, Paris/FR
Room 2
08:30-09:30 Workshop 1: Patient Communication simulation: Breaking Bad News
D. Carrie, Toulouse/FR & B. Chase, Msida/MT & C. Justich, Vienna/AT
17:00-18:00 Workshop 6: Bladder Cancer Staging and Response Assessment with MRI
T. Boellaard, Amsterdam/NL & S. van Koeverden, Nijmegen/NL
Room 3
08:30-09:30 Workshop 6: Bladder Cancer Staging and Response Assessment with MRI
T. Boellaard, Amsterdam/NL & S. van Koeverden, Nijmegen/NL
17:00-18:00 Workshop 3: Errors in Oncologic Imaging
A. Borgheresi, Ancona/IT & G. Cappello, Turin/IT
Room 4
08:30-09:30 Workshop 7: Ultrasound Workshop: Thyroid nodules and TIRADS
M. Radzina, Riga/LV & L. Bonello Msida/MT
17:00-18:00 Workshop 7: Ultrasound Workshop: Thyroid nodules and TIRADS
M. Radzina, Riga/LV & L. Bonello Msida/MT
Saturday, November 15
Room 1
08:30-09:30 Workshop 4: Lung Cancer Staging: Challenging cases and tips from the experts
G. Cicchetti, Rome/IT & A.R. Larici, Rome/IT
09:30-09:40 Break
09:40-10:40 Prostate Cancer
G. Cappello, Turin/IT & R-T. Hoffmann, Dresden/DE
09:40 MRI for prostate cancer early detection and screening: What’s new?, H.A. Vargas, New York/US
10:00 Staging and Therapy Monitoring of Prostate Cancer, J. Rübenthaler, Munich/DE
10:20 Basics of Radioligand Therapy: PSMA and Beyond, J. Rübenthaler, Munich/DE
10:40-11:10 Coffee Break
11:10-12:10 Atypical Metastases: Unusual Faces of Usual or Unusual Disease
N. Bogveradze, Vienna/AT & I. Kizildag Yirgin, Istanbul/TR
11:10 Brain, I. Trofimenko, Porto/PT
11:25 Bone, F. Lecouvet, Brussels/BE
11:40 Lung, A.R. Larici, Rome/IT
11:55 Liver, K. Kulpina, Msida/MT
12:10-12:15 Break
12:15-13:15 Technological Advances in Oncologic Imaging
G. Zamboni, Verona/IT & M. Zerunian, Rome/IT
12:15 Advancing Abdominal Imaging: The Impact of Photon Counting CT Technology, H-C. Becker, Standford/US
12:30 Whole-body Cancer Screening: Techniques and Protocols, K. Kenigsberg, Haifa/IS
12:45 Advanced MRI Technique for Bone Marrow Assessment, F. Lecouvet, Brussels/BE
13:00 AI and Digital Twinning in Oncology, B. Raghavan, Chennai/IN
13:15-13:30 Closing + Awarding Session
M. D’Anastasi, Msida/MT
Room 2
08:30-09:30 Workshop 2: Therapy Complications in Oncological Patients (CNS, Thorax, Abdomen)
W. Kunz, Munich/DE & D. Lambregts, Amsterdam/NL & S. Shivalingappa, Bangalore/IN
Room 3
08:30-09:30 Workshop 8: Cervical cancer staging with MRI: Basic and challenging cases
N. Bonanno, Birkirkara/MT & L. Fournier, Paris/FR
Room 4
08:30-09:30 Workshop 9: Breast MRI – Challenging cases
R. Pintican, Cluj-Napoca/RO & G. Sargsyan, Yerevan/AR
SPONSORING
Please click on the button below to find detailed information about sponsor options as well as the ESOI industry partners!
VIRTUAL CONGRESS BAG
We are delighted to offer you the virtual congess bag. Mark your calendar and save the dates!